Rocket Lab Corp SEC Filings

Rocket Lab Corporation filed a prospectus supplement covering the resale of up to 2,277,002 shares of its common stock. These shares were issued on April 14, 2026 in a private placement tied to Rocket Lab’s previously announced acquisition of Mynaric AG under a Stock Purchase Agreement dated September 25, 2025.

The filing notes that the prospectus supplement was made pursuant to the Stock Purchase Agreement and is part of Rocket Lab’s existing automatic shelf registration statement on Form S-3ASR. A legal opinion and related consent from Goodwin Procter LLP regarding the shares are included as exhibits.

Rocket Lab Corporation filed a prospectus supplement registering 2,277,002 shares of its common stock for resale by selling stockholders. These shares were issued on April 14, 2026 as partial consideration for the acquisition of Mynaric AG. The company will not receive any proceeds from sales of the registered shares; proceeds will go to the selling stockholders. Shares outstanding were 578,750,990 as of April 30, 2026. The prospectus supplement states the shares may be sold on Nasdaq, in OTC trades, privately negotiated transactions or other permitted methods under the Plan of Distribution.

Rocket Lab Corporation reported strong growth for the three months ended March 31, 2026, with total revenue of $200.3 million, up from $122.6 million a year earlier, as both launch services and space systems expanded. Launch Services generated $63.7 million and Space Systems $136.7 million.

The company’s net loss narrowed to $45.0 million from $60.6 million, while gross profit more than doubled to $76.5 million. Cash, cash equivalents and marketable securities totaled $1.48 billion, supported by $450.3 million of common stock sold under an at-the-market equity program.

Rocket Lab converted $118.1 million of 4.25% convertible notes into 23.0 million shares, leaving $37.6 million outstanding, and ended the quarter with backlog of $2.22 billion, about 36% expected within 12 months. Management highlighted continued development of its Neutron medium-lift launch vehicle and recent acquisitions expanding space systems capabilities.

Rocket Lab Corporation reported record first-quarter 2026 revenue of $200.3 million, driven by strong growth in both product and service sales. Revenue rose 63.5% year over year to $127.5 million in product revenue and $72.9 million in service revenue, producing a GAAP gross margin of 38.2% and non-GAAP gross margin of 43.0%.

The company ended the quarter with a record $2.2 billion backlog and access to more than $2 billion in total liquidity, supported by $450.3 million raised through at-the-market equity offerings. Despite this growth, Rocket Lab posted a GAAP net loss of $45.0 million, or $0.07 per share, and an Adjusted EBITDA loss of $11.8 million, both improved versus the prior year.

Management highlighted record new launch contracts, completion of the Mynaric acquisition, a definitive agreement to acquire Motiv Space Systems, and progress on the Neutron launch vehicle. For the second quarter of 2026, the company guides revenue between $225 million and $240 million with continued GAAP and non-GAAP gross margin expansion and an expected Adjusted EBITDA loss between $20 million and $26 million.

Rocket Lab Corporation completed the acquisition of all issued and outstanding shares of Mynaric AG, a provider of laser optical communications terminals for air, space, and mobile applications. Rocket Lab paid aggregate consideration of $155.3 million, consisting of a nominal cash payment and 2,277,002 shares of its common stock, with 109,943 shares placed into an indemnity escrow.

The closing consideration was primarily based on a $75 million base purchase price plus additional investments made by the sellers, with a corresponding reduction in potential earnout consideration; the sellers are no longer eligible for further earnout payments. The Rocket Lab common stock issued in the deal was an unregistered issuance relying on Section 4(a)(2) of the Securities Act and/or Regulation D. Mynaric will continue to be headquartered in Munich, giving Rocket Lab its first European footprint and expanding its role in satellite laser communications alongside its existing launch and space systems business.

Rocket Lab Corp filed an initial insider report showing that President of Rocket Lab USA Inc., Marvin Bradford Clevenger, beneficially owns 492,435 shares of Common Stock. This total includes 282,679 restricted stock units (RSUs) granted under the Rocket Lab Corporation 2021 Stock Option and Incentive Plan, where each RSU represents a contingent right to receive one share of Common Stock.

Rocket Lab Corporation is asking stockholders to vote at a virtual annual meeting on May 20, 2026 at 1:30 p.m. Pacific Time. Holders of 575,767,300 shares of common stock and 45,951,250 shares of Series A preferred stock as of March 30, 2026 can vote online.

Investors will vote on electing Class II director Edward H. Frank, ratifying Deloitte & Touche LLP as auditor, approving a non-binding say‑on‑pay resolution, and approving a subsidiary merger that removes a pass‑through voting provision in Rocket Lab USA, Inc.’s charter.

The proxy details board structure and independence, committee responsibilities, stockholder proposal procedures, and extensive executive pay disclosure. CEO Peter Beck’s 2025 base salary remains $800,000 and he received 132,426 RSUs with a target value of $8,000,000, while other named executives saw flat base salaries, no 2025 bonuses, and no new equity grants due to existing unvested holdings.